CompanionCBD is a veterinarian-owned and operated company.
CBD can help manage anxiety, pain, seizures, neuro-degenerative conditions and more in pets. We Believe, the therapeutic potential of CBD in the marketplace—as it pertains to veterinary care, especially—is untapped. This is due to the current market’s fascination with CBD “treats,” none of which contain enough compound to provide real therapeutic benefits.
Our soft chew, while extremely palatable to the pet due to its cheesy-bread flavor, delivers science-based concentrations of CBD capable of producing tangible, documentable therapeutic results. [Read More]
Equity is a stock or any other security representing an ownership interest.
December 20, 2019
March 21, 2020
Open to Investors
Inventory, Marketing, Salaries, StartEngine Platform Fees
Co- Founder, CEO and Director
A serial entrepreneur with over 23 years of global sales, branding, marketing, distribution and consulting experience. Brad has worked in a number of different industries, ranging for medical technology, to real estate, biotech/Pharma, environmental and entertainment distribution.
Dr. Josh Sosnow
Co-founder, Chief medical officer, CFO and Director
A practicing veterinarian for over 19 years, and advocate for the clinical use of CBD in clinical practice, Dr. Josh Sosnow is a nationally-recognized CBD educator in the veterinary community. His Principal Occupation is President at Sosnow Animal Hospitals, P.C and works with CompanionCBD about 15-20 hours a week.
Security Name: Common Stock
$1.00 per share
There are no additional research reports currently.